Janakiraman Subramanian, MD, MPH
Dr Janakiraman Subramanian is a thoracic medical oncologist at the Inova Schar Cancer Center. He is the Director of Thoracic Oncology at Inova Schar Cancer Institute. He leads the research program for thoracic oncology. He has been practicing thoracic oncology for over 14 years now and has extensive experience in the management of malignancies involving the lung, pleura, mediastinum, esophagus and head & neck. He has served as principal or co-investigator for several cooperative group and pharmaceutical clinical trials. He is actively involved in thoracic oncology research and has over 100 publications. He serves as member on the Global Multidisciplinary Practice Standards Committee for the International Association for the Study of Lung Cancer. .
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Astra ZenecaTopic:Speaker/AdvisorDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:DaiichiTopic:AdvisorDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Jazz PharmaTopic:SpeakerDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:JanssenTopic:SpeakerDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:OncohostTopic:speakerDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:PfizerTopic:advisorDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GLGTopic:advisorDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GuidepointTopic:advisorDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Cancer Expert NowTopic:advisorDate added:11/01/2023Date updated:10/09/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Regeneron/SanofiTopic:advisorDate added:11/01/2023Date updated:10/09/2025

Facebook
X
LinkedIn
Forward